In a woman with a right ovarian complex cyst measuring 5.5 × 4.0 cm, displaying multiple septations, reticular echoes, and no internal vascularity on color Doppler, what is the most likely diagnosis and the optimal management?

Diagnosis and Management of Right Ovarian Complex Cyst (5.5 × 4.0 cm)

This is most likely a hemorrhagic cyst, and since it measures >5 cm in a premenopausal woman, you should perform follow-up ultrasound in 8-12 weeks to confirm resolution or stability. 1

Diagnostic Assessment

The ultrasound features you describe are classic for a hemorrhagic cyst:

• Multiple septations with reticular echoes (representing fibrin strands and retracting clot)
• Absence of internal vascularity on color Doppler
• Size 5.5 × 4.0 cm

These findings align precisely with the O-RADS US classification system's description of typical hemorrhagic cysts, which characteristically show a reticular pattern with fine discontinuous linear echoes, concave margins from retracting clot, and no internal blood flow 1. The absence of vascularity is particularly reassuring, as it differentiates the retractile clot from solid tissue 1.

This lesion would be classified as O-RADS 2 (Almost Certainly Benign, <1% risk of malignancy) when it demonstrates these classic features 1.

Management Algorithm Based on Size and Menopausal Status

If Patient is Premenopausal:

For cysts >5 cm but <10 cm (your case):

• Perform follow-up ultrasound in 8-12 weeks 1
• The optimal timing is during the proliferative phase (after menstruation) to allow functional cysts to involute 1
• If the cyst resolves or decreases by ≥10-15%, no further follow-up is needed 2
• If the cyst persists unchanged or enlarges, refer to gynecologist or ultrasound specialist, or consider MRI 1

For cysts ≤5 cm:

• No further management required 1

If Patient is Postmenopausal:

Hemorrhagic cysts should not occur in postmenopausal women 1. If this patient is postmenopausal:

• Immediate referral to ultrasound specialist or gynecologist
• Consider MRI for further characterization
• Higher suspicion warranted despite benign-appearing features

Key Clinical Pitfalls to Avoid

1. Size measurement matters: At 5.5 cm, this crosses the threshold requiring follow-up. Cysts ≤5 cm need no management, but larger ones require surveillance to ensure they're truly functional and to detect any wall abnormalities that might be missed in larger cysts 1.

2. Don't confuse septations with solid components: The multiple septations you describe are thin fibrin strands, not solid tissue. True solid components would show internal vascularity on Doppler 1. Research shows fibrin strands have a likelihood ratio of 40 for hemorrhagic cyst diagnosis, and when combined with smooth walls and no septations, the LR increases to 200 3.

3. Incomplete evaluation risk: If the cyst cannot be fully visualized transvaginally due to size, perform transabdominal ultrasound to ensure complete assessment 1. Missing solid components or papillary projections would change management entirely.

4. Document menopausal status: This fundamentally changes the management pathway, as hemorrhagic cysts are physiologic in premenopausal women but pathologic in postmenopausal women 1.

What to Tell the Patient

• This appears to be a functional hemorrhagic cyst (blood-filled cyst related to normal ovarian function)
• Risk of malignancy is <1% with these classic benign features 1
• Repeat ultrasound in 8-12 weeks is needed because the cyst is larger than 5 cm
• Most hemorrhagic cysts resolve spontaneously within this timeframe
• If it persists or grows, gynecology referral will be needed for further evaluation
• No immediate intervention required unless symptoms develop (severe pain, torsion, rupture)

Additional Considerations

CA-125 testing is not routinely indicated for classic benign-appearing lesions in premenopausal women, as it has poor positive predictive value (0.35) despite good negative predictive value (0.95) 4. It adds little diagnostic value when ultrasound features are clearly benign.

Surgical intervention is reserved for:

• Cysts that persist or enlarge on follow-up
• Development of solid components or papillary projections
• Symptomatic cysts causing pain or complications
• Any complex cyst in postmenopausal women, particularly if >5 cm 4

The evidence strongly supports conservative management with surveillance for this size hemorrhagic cyst in premenopausal women, as studies show septated cystic tumors without solid areas or papillary projections have extremely low malignancy risk and can be safely followed sonographically 5.